These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6341195)

  • 21. Antibodies to isolated hepatocytes in chronic active liver disease. Identification and diagnostic significance of bile canalicular antibodies.
    Diederichsen H; Riisom K; Andersen I; Hage E
    Scand J Gastroenterol; 1986 Mar; 21(2):146-50. PubMed ID: 3715383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired monocyte function in primary biliary cirrhosis.
    Olmos JM; García JD; Jiménez A; de Castro S
    Allergol Immunopathol (Madr); 1988; 16(5):353-8. PubMed ID: 3228054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to nuclear lamins in autoimmune liver disease.
    Wesierska-Gadek J; Penner E; Hitchman E; Sauermann G
    Clin Immunol Immunopathol; 1988 Oct; 49(1):107-15. PubMed ID: 3044653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins.
    Dighiero G; Lymberi P; Monot C; Abuaf N
    Clin Exp Immunol; 1990 Oct; 82(1):52-6. PubMed ID: 2208796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunofluorescent detection of anti-cytoskeleton antibodies using vinblastine-treated mononuclear cells.
    Zauli D; Crespi C; Bianchi FB; Pisi E
    J Immunol Methods; 1985 Sep; 82(1):77-82. PubMed ID: 4040947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antinuclear autoantibodies in chronic liver diseases.
    Konikoff F; Isenberg DA; Barrison I; Theodor E; Shoenfeld Y
    Hepatogastroenterology; 1989 Oct; 36(5):341-5. PubMed ID: 2620901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance.
    Kurki P; Miettinen A; Linder E; Pikkarainen P; Vuoristo M; Salaspuro MP
    Gut; 1980 Oct; 21(10):878-84. PubMed ID: 7002738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticalmodulin autoantibody in liver diseases: a new antibody against a cytoskeleton-related protein.
    Ikeda Y; Toda G; Hashimoto N; Aotsuka S; Yokohari R; Maruyama T; Oka H
    Hepatology; 1987; 7(2):285-93. PubMed ID: 3557308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibody against a 78 kDa membrane protein of HepG2 cell in the sera of patients with alcoholic liver diseases.
    Numata T; Kato J; Kohgo Y; Katsuki S; Kondo H; Niitsu Y
    J Gastroenterol; 1995 Dec; 30(6):751-7. PubMed ID: 8963393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity in chronic liver disease caused by hepatitis delta virus.
    Zauli D; Crespi C; Bianchi FB; Craxi A; Pisi E
    J Clin Pathol; 1986 Aug; 39(8):897-9. PubMed ID: 3745480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to vimentin intermediate filaments in sera from patients with SLE and RA: quantitation by solid phase radioimmunoassay.
    Alcover A; Ramirez-Lafita F; Hernandez C; Nieto A; Avila J
    J Rheumatol; 1985 Apr; 12(2):233-6. PubMed ID: 3897530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis.
    Yoshida T; Bonkovsky H; Ansari A; Danner D
    Gastroenterology; 1990 Jul; 99(1):187-94. PubMed ID: 2188870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?
    Davis PA; Leung P; Manns M; Kaplan M; Munoz SJ; Gorin FA; Dickson ER; Krawitt E; Coppel R; Gershwin ME
    Hepatology; 1992 Nov; 16(5):1128-36. PubMed ID: 1330864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.
    Mutimer DJ; Fussey SP; Yeaman SJ; Kelly PJ; James OF; Bassendine MF
    Hepatology; 1989 Oct; 10(4):403-7. PubMed ID: 2673968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBsAg-associated albumin receptors and antialbumin antibodies in sera of patients with liver disease.
    Thung SN; Gerber MA
    Gastroenterology; 1981 Feb; 80(2):260-4. PubMed ID: 6161062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of C3b-binding in chronic liver diseases.
    Hautanen A; Salaspuro MP
    Scand J Gastroenterol; 1981; 16(4):505-12. PubMed ID: 7323688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of passive hemagglutination and immunofluorescence methods for the detection of mitochondrial antibodies in sera from patients with liver diseases.
    Katono S
    Gastroenterol Jpn; 1980; 15(3):233-40. PubMed ID: 6995220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis.
    Löhr H; Treichel U; Poralla T; Manns M; Meyer zum Büschenfelde KH; Fleischer B
    Hepatology; 1990 Dec; 12(6):1314-20. PubMed ID: 2258147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.
    Saxena S; Nouri-Aria KT; Anderson MG; Eddleston AL; Williams R
    Clin Exp Immunol; 1986 Mar; 63(3):541-8. PubMed ID: 3486732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.
    Masuda J; Omagari K; Ohba K; Hazama H; Kadokawa Y; Kinoshita H; Hayashida K; Hayashida K; Ishibashi H; Nakanuma Y; Kohno S
    Dig Dis Sci; 2003 May; 48(5):932-8. PubMed ID: 12772793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.